AD504
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for AD504, covering 2022-09-02 to 2026-08-12. Get the full timeline:
Most recent: Clinical Trial Results: Parallel Arm Trial of AD109 and AD504 In Patients With OSA [Phase 2]